Rituximab reduces anti-cardiolipin levels in patients with systemic lupus erythematosus

被引：0
|
作者：
R Martínez-Pérez
A Muñoz-Jiménez
S Rodríguez-Montero
A Fernández-Nebro
L Carreño
J L Marenco
机构：
[1] Valme University Hospital,Rheumatology Unit
[2] Malaga Civil Hospital,Rheumatology Unit
[3] Gregorio Marañón University Hospital,Rheumatology Unit
来源：
Journal of Translational Medicine | / 8卷 / Suppl 1期
关键词：
Systemic Lupus Erythematosus; Systemic Lupus Erythematosus Patient; Lupus Anticoagulant; Anticardiolipin Antibody; Physician Global Assessment;
D O I：
10.1186/1479-5876-8-S1-P69
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [11] SPLENIC AND RENAL INFARCTION IN SYSTEMIC LUPUS-ERYTHEMATOSUS - ASSOCIATION WITH ANTI-CARDIOLIPIN ANTIBODIES
    ARNOLD, MH
    SCHRIEBER, L
    CLINICAL RHEUMATOLOGY, 1988, 7 (03) : 406 - 410
  • [12] Rituximab reduces the hospitalization in patients with systemic lupus erythematosus
    R Martínez-Pérez
    A Fernández-Nebro
    M López-Lasanta
    M L Velloso-Feijoo
    A Muñoz-Jiménez
    J López Longo
    J L Marenco
    Journal of Translational Medicine, 8 (Suppl 1)
  • [13] RELATIONSHIP BETWEEN ANTI-CARDIOLIPIN AND ANTI-ENDOTHELIAL CELL ANTIBODIES IN SYSTEMIC LUPUS-ERYTHEMATOSUS
    VISMARA, A
    MERONI, PL
    TINCANI, A
    HARRIS, EN
    BARCELLINI, W
    BRUCATO, A
    KHAMASHTA, M
    HUGHES, GRV
    ZANUSSI, C
    BALESTRIERI, G
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 1988, 74 (02): : 247 - 253
  • [14] OPTIMIZING ELIMINATION OF ANTI-CARDIOLIPIN ANTIBODIES IN PATIENTS WITH ANTIPHOSPHOLIPID SYNDROME AS A COMPONENT OF PATHOGENETIC THERAPY FOR PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS
    Emelyanova, O.
    Rusanova, O.
    Trofimenko, A.
    AGING CLINICAL AND EXPERIMENTAL RESEARCH, 2024, 36 : S474 - S474
  • [15] OCCLUSION OF SMALL HEPATIC VEINS ASSOCIATED WITH SYSTEMIC LUPUS-ERYTHEMATOSUS WITH THE LUPUS ANTICOAGULANT AND ANTI-CARDIOLIPIN ANTIBODY
    NAKAMURA, H
    UEHARA, H
    OKADA, T
    KAMBE, H
    KIMURA, Y
    ITO, H
    HAYASHI, E
    YAMAMOTO, H
    KISHIMOTO, S
    HEPATO-GASTROENTEROLOGY, 1989, 36 (05) : 393 - 397
  • [16] CLINICAL-SIGNIFICANCE OF ANTI-CARDIOLIPIN ANTIBODIES IN SYSTEMIC LUPUS
    WERNICK, R
    AMERICAN JOURNAL OF MEDICINE, 1989, 87 (05): : 600 - 600
  • [17] IGG CLASS ANTI-CARDIOLIPIN ANTIBODY AS A POSSIBLE MARKER FOR EVALUATING FETAL RISK IN PATIENTS WITH SYSTEMIC LUPUS-ERYTHEMATOSUS
    SHIMADA, K
    KOIKE, T
    ICHIKAWA, K
    TSUTSUMI, A
    TAKABAYASHI, K
    TOMIOKA, H
    YOSHIDA, S
    JOURNAL OF AUTOIMMUNITY, 1989, 2 (06) : 843 - 849
  • [18] β2-Glycoprotein I-Dependent Anti-Cardiolipin Antibodies Associated With Periodontitis in Patients With Systemic Lupus Erythematosus
    Wang, Chen-Ying
    Chyuan, I-Tsu
    Wang, Ya-Li
    Kuo, Mark Yen-Ping
    Chang, Ching-Wen
    Wu, King-Jean
    Hsu, Ping-Ning
    Nagasawa, Toshiyuki
    Wara-aswapati, Nawarat
    Chen, Yi-Wen
    JOURNAL OF PERIODONTOLOGY, 2015, 86 (08) : 995 - 1004
  • [19] Sex Hormones and Prolactin Levels and Their Association with Anti Cardiolipin Antibody in Patients with Systemic Lupus Erythematosus
    Raeisi, Dariyush
    Zare, Mohammad Erfan
    Kansestani, Atefeh Nasir
    Sherkatolabbasieh, Hamid Reza
    Shafiezadeh, Shiva
    IRANIAN JOURNAL OF ALLERGY ASTHMA AND IMMUNOLOGY, 2018, 17 (04) : 336 - 345
  • [20] Anti-cardiolipin and anti-beta2 glycoprotein I antibodies in Indian patients with systemic lupus erythematosus:: association with the presence of seizures
    Shrivastava, A
    Dwivedi, S
    Aggarwal, A
    Misra, R
    LUPUS, 2001, 10 (01) : 45 - 50
12345